The authors regret an error in section 2.3 of the Methods section of the manuscript. We inadvertently listed the Arl13b antibody lot number (455–8JD-29) in place of the antibody clone number. Thus, the antibody designation should read, Arl13b (NeuroMab N295B/66; 1:500).
The authors would like to apologise for any inconvenience caused.